US Patent 7294613 Beta-defensins
Patent 7294613 was granted and assigned to ZymoGenetics on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
David A. Adler0
James L. Holloway0
Nand Baindur0
Paul O. Sheppard0
Stephanie Beigel-Orme0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+366 characters)
Article
Patent abstract
The present invention relates to polynucleotide and polypeptide molecules for zamp1, a novel member of the β-defensin family. The polypeptides, and polynucleotides encoding them, exhibit anti-microbial activity and may be used in the study or treatment of microbial infections. The present invention also includes antibodies to the zamp1 polypeptides.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07294613 Beta-defensins US Patent 7294613 Beta-defensins
Infobox
Patent Number
072946130
Patent Number
72946130
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072946130
Date of Patent
November 13, 2007
0Patent Application Number
100911660
Date Filed
March 5, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07294613 Beta-defensins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07294613
Date of patent
November 13, 2007
Patent application number
10091166
Date Filed
March 5, 2002
Patent primary examiner
Find more entities like US Patent 7294613 Beta-defensins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.